Yutaka Niihara - 06 Dec 2021 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
Yutaka Niihara, M.D., M.P.H.
Issuer symbol
EMMA
Transactions as of
06 Dec 2021
Net transactions value
+$10,456
Form type
4
Filing time
10 Dec 2021, 12:19:42 UTC
Previous filing
06 Dec 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $2,235 +1,500 +0.01% $1.49 11,091,706 06 Dec 2021 Direct F1, F2
transaction EMMA Common stock, $0.001 par value Purchase $2,945 +1,900 +0.02% $1.55 11,093,606 07 Dec 2021 Direct F2, F3
transaction EMMA Common stock, $0.001 par value Purchase $1,896 +1,200 +0.01% $1.58 11,094,806 08 Dec 2021 Direct F2, F4
transaction EMMA Common stock, $0.001 par value Purchase $3,380 +2,000 +0.02% $1.69 11,096,806 09 Dec 2021 Direct F2, F5
holding EMMA Common stock, $0.001 par value 92,794 06 Dec 2021 By Hope International Hospice, Inc. F6
holding EMMA Common stock, $0.001 par value 63,000 06 Dec 2021 By Soomi Niihara
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3), (4) and (5) to this Form 4.
F2 The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.56, inclusive.
F4 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.56 to $1.65, inclusive.
F5 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.60 to $1.78, inclusive.
F6 Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.